Company Profile & Origins
Sanofi is a global biopharmaceutical company headquartered in Paris, France. It has more than a century of scientific history and continuous innovation. The company was established in 2004 after Sanofi-Synthélabo and Aventis joined forces, creating one of Europe’s most respected pharmaceutical groups.
Its vaccine division, Sanofi Pasteur, began with the scientific breakthroughs of Louis Pasteur, whose discoveries helped shape modern immunology and the rise of preventive healthcare.
Today, Sanofi operates in over 100 countries, supported by manufacturing sites and research centers across Europe, North America, and Asia. Through this global presence, Sanofi continues to advance global health by delivering modern, effective, and reliable vaccines for people of all ages.
Research, Innovation & Technology
Sanofi Pasteur focuses solely on vaccine development and production. Over the years, it has created many of the world’s most widely used vaccines and continues to invest heavily in next-generation platforms.
Key strengths include:
Recombinant and conjugate technologies that increase immune protection and durability.
Adjuvant formulations that further improve vaccine effectiveness.
Global cold-chain systems that protect vaccine potency from production to patient.
Strong partnerships exploring mRNA and combination vaccines, which simplify schedules and improve access worldwide.
Through continuous innovation, Sanofi aims to strengthen both public health programs and private immunization efforts.
Vaccine Portfolio
Sanofi offers one of the most comprehensive vaccine portfolios in the world, protecting against more than 20 diseases that affect infants, adolescents, adults, and older individuals. With this wide range, Sanofi plays an essential role in travel medicine, national immunization programs, and workplace vaccination.
Key vaccines:
Influenza: Vaxigrip® and Vaxigrip Tetra®
Tetanus, Diphtheria, Pertussis: Adacel®
Polio: Imovax Polio®
Hepatitis A & B: Avaxim® and Heberbiovac HB®
Typhoid: Typhim Vi®
Meningococcal: Menactra®
Rabies: Verorab®
MMR: Trimovax®
This broad coverage ensures dependable protection for healthcare institutions, families, companies, and employees.
Medical Breakthroughs & Global Contributions
Sanofi has played a major role in vaccine history. The company developed the world’s first polio and rabies vaccines and helped introduce large-scale flu vaccination programs, as well as combination vaccines that reduce the number of injections required for children.
Today, Sanofi works closely with WHO, UNICEF, Gavi, and many national health ministries to expand vaccine availability, especially in developing countries. Moreover, the company is advancing research in RSV, next-generation influenza, and combined COVID-flu vaccine products.
Presence in the Philippines
Sanofi has been serving the Philippines for more than 60 years, with its office in Taguig supporting partnerships with hospitals, pharmacies, and companies across the country. Many of its vaccines are already registered with the Philippine FDA and are widely used in both public and private sectors.
In corporate health programs, Vaxigrip® Tetra, Adacel®, and Menactra® are among the most commonly administered vaccines. Consequently, Sanofi has become a trusted partner for workplace immunization and preventive care.
Shared Commitment to Prevention
Through its partnership with Sanofi, Affinity Vaccines brings world-class vaccine protection to Filipino organizations. Backed by over a century of scientific leadership and innovation, Sanofi’s trusted vaccine portfolio helps Affinity ensure comprehensive, safe, and high-quality immunization services for employees and their dependents across the country.
Partner with Affinity Vaccines and Sanofi to strengthen your organization’s health and resilience.
Contact vaccines@affinity.com.ph to begin your workplace immunization program today.
📩 Request for a Corporate Vaccination Proposal